Camzyos Bridge Program

Funded
About
The Camzyos Bridge Program is designed for patients using the drug Camzyos, providing support by covering the cost of Camzyos for commercially-insured patients if there is a delay in coverage determination. This program ensures that eligible patients can continue their treatment without interruption under specified conditions.
Insurance requirements: Commercially insured, Underinsured
Enrollment Forms
Enrollment Form
Benefits
•18 maximum fills per year
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: No
•Activation Required: No
Program Details
•Only valid for commerciallyinsured patients being treated with CAMZYOS
•If a coverage determination is delayed for twenty (20) calendar days or more, the patient will be provided CAMZYOS at no cost until coverage is received, a prior authorization is denied and not appealed, or for 18 dispenses, whichever is earlier
•An appeal of any prior authorization denial must be made within 60 days or as per payer guidelines to remain in the Program
•Patients continuing into the following year will be reverified for eligibility in January
•For patients whose insurance changes during the course of program participation and otherwise remain eligible, a new prior authorization must be submitted
•Program reserves the right to reverify patient’s insurance coverage at any point during the patient’s participation in the Program
•Offer is not conditioned on any past, present or future purchase, including refills
•Patients who have prescription insurance coverage through Medicare, Medicaid, or any other federal or state healthcare program are not eligible
•For more information patients must call 8552269967, Monday to Friday, 8 AM to 11 PM ET